SLC29A1 and meningioma: The role of hENT1 in gemcitabine sensitivity has been reported in various tumors, including pancreatic cancer [55], meningioma [56], biliary tract cancer (BTC) [57], and non-small cell lung cancer (NSCLC) [58].